- Profile
- Personal Information
- Publications
Experts in Immunology
Priti Bajpai M.J.M. (MARC) BONTEN Rolee Sharma Douglas Darling Donald Demuth Alba Ruiz de Andrés Javier MartÃnez-Picado Prof. Sarat Kumar Dalai Prof. Sarat Kumar Dalai Julià Blanco Cezmi A. Akdis Dr Joanna Kirman Arianna Calcinotto Dennis W. McGee Liz Hedstrom Daniela Brina Joan Press Neil E. Simister Mausumi Sikdar (Nee Bhakta ) Asmita Das View MoreVivian Liu has served as a Director since January 2011. Additionally, Ms. Liu served as our President & CEO from January 2011 to January 2012. Ms. Liu is the Chairperson of the Audit Committee and is a member of the Compensation and Governance and Nominating Committees. In 1995, Ms. Liu co-founded NexMed, Inc., which was renamed Apricus Biosciences, Inc. (NASDAQ: APRI) in 2010. Ms. Liu served as NexMed's President and Chief Executive Officer from 2007-2009, after having served in various executive capacities. Ms. Liu was appointed to the NexMed Board of Directors in 2007 and served as its Chairman of the Board from 2009-2010. Prior to co-founding NexMed, Ms. Liu was the Commercial Attaché with the Delegation of Quebec in Los Angeles, responsible for business development projects for the medical, pharmaceutical and biotechnology industries. Ms. Liu is currently a partner in OxOnc Development LP, a privately held oncology development company funded by Orbimed Advisors and a member of the Board of Directors of Cesca Therapeutics, Inc., (Nasdaq: KOOL). Vivian Liu has served as a Director since January 2011. Additionally, Ms. Liu served as our President & CEO from January 2011 to January 2012. Ms. Liu is the Chairperson of the Audit Committee and is a member of the Compensation and Governance and Nominating Committees. In 1995, Ms. Liu co-founded NexMed, Inc., which was renamed Apricus Biosciences, Inc. (NASDAQ: APRI) in 2010. Ms. Liu served as NexMed's President and Chief Executive Officer from 2007-2009, after having served in various executive capacities. Ms. Liu was appointed to the NexMed Board of Directors in 2007 and served as its Chairman of the Board from 2009-2010. Prior to co-founding NexMed, Ms. Liu was the Commercial Attaché with the Delegation of Quebec in Los Angeles, responsible for business development projects for the medical, pharmaceutical and biotechnology industries. Ms. Liu is currently a partner in OxOnc Development LP, a privately held oncology development company funded by Orbimed Advisors and a member of the Board of Directors of Cesca Therapeutics, Inc., (Nasdaq: KOOL).
Vivian Liu has served as a Director since January 2011. Additionally, Ms. Liu served as our President & CEO from January 2011 to January 2012. Ms. Liu is the Chairperson of the Audit Committee and is a member of the Compensation and Governance and Nominating Committees. In 1995, Ms. Liu co-founded NexMed, Inc., which was renamed Apricus Biosciences, Inc. (NASDAQ: APRI) in 2010. Ms. Liu served as NexMed's President and Chief Executive Officer from 2007-2009, after having served in various executive capacities. Ms. Liu was appointed to the NexMed Board of Directors in 2007 and served as its Chairman of the Board from 2009-2010. Prior to co-founding NexMed, Ms. Liu was the Commercial Attaché with the Delegation of Quebec in Los Angeles, responsible for business development projects for the medical, pharmaceutical and biotechnology industries. Ms. Liu is currently a partner in OxOnc Development LP, a privately held oncology development company funded by Orbimed Advisors and a member of the Board of Directors of Cesca Therapeutics, Inc., (Nasdaq: KOOL).